Healthcare · BSX
Boston Scientific Corporation — quantitative score history
AIStockAnalytics scores Boston Scientific Corporation every day as part of its Healthcare coverage. Over the period shown, the hybrid score averaged 40 out of 100, ranging from 34 to 48. The most recent public score, from 30 Sep 2026, was 42 (technical 25, fundamental 61).
Hybrid score history (delayed 30 days)
19 Dec 2025 – 30 Sep 2026 · scale 0–100 · dashed line = 50
Pro (29 €/month) shows current technical, fundamental and hybrid scores for all 1,400+ stocks, sector-calibrated models and Excel export. Start free or buy today's full report for 19 €.
Score vs. what happened next
| Date | Hybrid | Technical | Fundamental | Price, next 30 d |
|---|---|---|---|---|
| 2026-09-30 | 42 | 25 | 61 | -2.7 % |
| 2026-08-31 | 38 | 10 | 70 | -6.5 % |
| 2026-07-31 | 38 | 10 | 70 | +0.0 % |
| 2026-06-30 | 38 | 11 | 68 | +0.0 % |
| 2026-05-31 | 40 | 27 | 60 | -2.9 % |
| 2026-04-29 | 37 | 22 | 61 | -16.0 % |
| 2026-03-31 | 37 | 25 | 55 | -10.2 % |
| 2026-02-28 | 44 | 35 | 56 | -10.0 % |
| 2026-01-31 | 47 | 41 | 56 | -17.8 % |
| 2025-12-31 | 46 | 41 | 53 | -3.8 % |
Key figures (as of 30 Sep 2026)
How the score works
The hybrid score combines a technical model (momentum, trend, volume and volatility signals) with a fundamental model (valuation, profitability, growth and balance-sheet quality). It reflects expected relative strength over the next 30 days versus other covered stocks. Read the methodology.
Other Healthcare stocks
- Cosmo N.V. A
- Cardinal Health, Inc.
- Camurus AB
- Cantargia AB
- Carasent AB
- CellaVision AB
- The Cigna Group
- Cinclus Pharma Holding AB
- Centene Corporation
- The Cooper Companies, Inc.
- Cencora, Inc.
- C-RAD AB ser. B
General, impersonal research data — not investment advice. Scores shown here are delayed by 30 days. Past performance, including the historical figures on this page, is not indicative of future results.